A psychoncological study of lymphocyte subpopulations in relation to pleasure-related neurobiochemistry and sexual and spiritual profile to Rorschach's test in early or advanced cancer patients

Journal of Biological Regulators and Homeostatic Agents

Volumn 17, Issue 4, 2003, Pages 322-326

  Messina, G ^a   Lissoni, Paolo ^a   Bartolacelli, E ^a   Tancini, G ^a   Villa, S ^a   Gardani, G S ^a   Brivio, F ^a  

^a SAN GERARDO HOSPITAL   (Italy)

Author keywords

Apomorphine; Lymphocyte subpopulations; Psychoneuroimmunology; Rorschach's test

Indexed keywords

APOMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 2; PROLACTIN;

ADULT; ADVANCED CANCER; ARTICLE; BLOOD LEVEL; BREAST CANCER; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOPAMINERGIC SYSTEM; DRUG SENSITIVITY; EARLY CANCER; FEMALE; HELPER CELL; HISTOPATHOLOGY; HORMONE RELEASE; HUMAN; IMMUNE DEFICIENCY; IMMUNE STATUS; IMMUNOSUPPRESSIVE TREATMENT; LUNG CANCER; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; MENTAL HEALTH; METASTASIS; NATURAL KILLER CELL; NEUROENDOCRINOLOGY; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; RELIGION; SEXUAL FUNCTION; SEXUALITY; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

EID: 1842423600     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Rubinow DR. Brain, behavior and immunity: An interactive system. J Natl Cancer Inst Monogr 1990; 10: 79-82.
2. Lissoni P, Cangemi P, Pirato D, et al. A review on cancer-psychospiritual status interactions. Neuroendocrinol Lett 2001; 22: 175-80.
3. Rotrosen J, Angrist B, Gershon S, et al. Neuroendocrine effects of apomorphine. Br J Psychiatry 1979; 135: 444-56.
4. Surmann A, Havemann-Reinecke U. Injection of apomorphine: A test to predict individual different dopaminiergic sensitivity? J Neural Transm Suppl 1995; 45: 143-5.
5. Lissoni P, Messina G, Vaghi M, et al. A psychoneuroendocrine study of brain dopaminergic sensitivity in locally limited or metastic cancer patients. In vivo 2003; 17: 647-50.
6. Maltoni M, Pirovano M, Nanni O, et al. Biological indices predictive of survival in 519 Italian terminally ill cancer patients. J Pain Symptom Manage 1997; 13: 1-9.
7. Stanley KE. Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst 1980; 65: 25-32.
8. Atzpodien J, Kirchner H. Cancer, cytokinesm and cytotoxic cells: Interleukin-2 in the immunotherapy of human neoplasms. Klin Wochenschr 1990; 68: 1-11.
9. Fumagalli L, Lissoni P, Di Felice G, et al. Pretreatment serum markers and lymphocyte response to interleukin-2 therapy. Br J Cancer 1999; 80: 407-11.
10. Rorschach H. Psychodiagnostics. Hans Huber, ed. Bern, Stuttgart, Toronto: Verlag, 1921.